Selected research
Market Structure
Global Diagnosis and Treatment Of Hemorrhoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Diagnosis and Treatment Of Hemorrhoids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Diagnosis and Treatment Of Hemorrhoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diagnosis and Treatment Of Hemorrhoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diagnosis and Treatment Of Hemorrhoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Diagnosis and Treatment Of Hemorrhoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diagnosis and Treatment Of Hemorrhoids include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Olympus Corporation, Novartis AG, Johnson & Johnson Services, Inc, GlaxoSmithKline, F. Hoffmann-La Roche Ltd, Cook Medical and CONMED Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Diagnosis and Treatment Of Hemorrhoids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diagnosis and Treatment Of Hemorrhoids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diagnosis and Treatment Of Hemorrhoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnosis and Treatment Of Hemorrhoids market size, projected growth trends, production technologies, key applications, and end-use industries.
Diagnosis and Treatment Of Hemorrhoids Segment by Company
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Olympus Corporation
Novartis AG
Johnson & Johnson Services, Inc
GlaxoSmithKline
F. Hoffmann-La Roche Ltd
Cook Medical
CONMED Corporation
Boston Scientific Corporation
Boehringer Ingelheim GmbH
Bayer AG
AstraZeneca
Abbott Laboratories
Diagnosis and Treatment Of Hemorrhoids Segment by Type
Infrared Coagulator
Cryotherapy Device
Bipolar Probe
Sclerotherapy Injector
Hemorrhoid Laser Probes
Others
Diagnosis and Treatment Of Hemorrhoids Segment by Application
Hospital and Clinics
Homecare
Others
Diagnosis and Treatment Of Hemorrhoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnosis and Treatment Of Hemorrhoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnosis and Treatment Of Hemorrhoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnosis and Treatment Of Hemorrhoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Diagnosis and Treatment Of Hemorrhoids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnosis and Treatment Of Hemorrhoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diagnosis and Treatment Of Hemorrhoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Diagnosis and Treatment Of Hemorrhoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Infrared Coagulator
- Cryotherapy Device
- Bipolar Probe
- Sclerotherapy Injector
- Hemorrhoid Laser Probes
- Others
Applications
- Hospital and Clinics
- Homecare
- Others
Companies covered
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Olympus Corporation
- Novartis AG
- Johnson & Johnson Services, Inc
- GlaxoSmithKline
- F. Hoffmann-La Roche Ltd
- Cook Medical
- CONMED Corporation
- Boston Scientific Corporation
- Boehringer Ingelheim GmbH
- Bayer AG
- AstraZeneca
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Diagnosis and Treatment Of Hemorrhoids Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Diagnosis and Treatment Of Hemorrhoids Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Diagnosis and Treatment Of Hemorrhoids Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Diagnosis and Treatment Of Hemorrhoids Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Diagnosis and Treatment Of Hemorrhoids Market Dynamics
- 2.1 Diagnosis and Treatment Of Hemorrhoids Industry Trends
- 2.2 Diagnosis and Treatment Of Hemorrhoids Industry Drivers
- 2.3 Diagnosis and Treatment Of Hemorrhoids Industry Opportunities and Challenges
- 2.4 Diagnosis and Treatment Of Hemorrhoids Industry Restraints
3 Diagnosis and Treatment Of Hemorrhoids Market by Manufacturers
- 3.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Manufacturers (2021-2026)
- 3.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Manufacturers (2021-2026)
- 3.3 Global Diagnosis and Treatment Of Hemorrhoids Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Diagnosis and Treatment Of Hemorrhoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Diagnosis and Treatment Of Hemorrhoids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Diagnosis and Treatment Of Hemorrhoids Manufacturers, Product Type & Application
- 3.7 Global Diagnosis and Treatment Of Hemorrhoids Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Diagnosis and Treatment Of Hemorrhoids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Diagnosis and Treatment Of Hemorrhoids Players Market Share by Revenue in 2025
- 3.8.3 2025 Diagnosis and Treatment Of Hemorrhoids Tier 1, Tier 2, and Tier 3
4 Diagnosis and Treatment Of Hemorrhoids Market by Type
- 4.1 Diagnosis and Treatment Of Hemorrhoids Type Introduction
- 4.1.1 Infrared Coagulator
- 4.1.2 Cryotherapy Device
- 4.1.3 Bipolar Probe
- 4.1.4 Sclerotherapy Injector
- 4.1.5 Hemorrhoid Laser Probes
- 4.1.6 Others
- 4.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type
- 4.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Type (2021-2032)
- 4.2.3 Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Type (2021-2032)
- 4.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type
- 4.3.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Type (2021-2032)
- 4.3.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Type (2021-2032)
5 Diagnosis and Treatment Of Hemorrhoids Market by Application
- 5.1 Diagnosis and Treatment Of Hemorrhoids Application Introduction
- 5.1.1 Hospital and Clinics
- 5.1.2 Homecare
- 5.1.3 Others
- 5.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application
- 5.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Application (2021-2032)
- 5.2.3 Global Diagnosis and Treatment Of Hemorrhoids Sales Market Share by Application (2021-2032)
- 5.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application
- 5.3.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Application (2021-2032)
- 5.3.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Application (2021-2032)
6 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region
- 6.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region (2021-2032)
- 6.2.1 Global Diagnosis and Treatment Of Hemorrhoids Sales by Region (2021-2026)
- 6.2.2 Global Diagnosis and Treatment Of Hemorrhoids Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Diagnosis and Treatment Of Hemorrhoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Diagnosis and Treatment Of Hemorrhoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region
- 7.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region
- 7.1.1 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region (2021-2026)
- 7.1.3 Global Diagnosis and Treatment Of Hemorrhoids Revenue by Region (2027-2032)
- 7.1.4 Global Diagnosis and Treatment Of Hemorrhoids Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Diagnosis and Treatment Of Hemorrhoids Revenue (2021-2032)
- 7.2.2 North America Diagnosis and Treatment Of Hemorrhoids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Diagnosis and Treatment Of Hemorrhoids Revenue (2021-2032)
- 7.3.2 Europe Diagnosis and Treatment Of Hemorrhoids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Diagnosis and Treatment Of Hemorrhoids Revenue (2021-2032)
- 7.4.2 Asia-Pacific Diagnosis and Treatment Of Hemorrhoids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Diagnosis and Treatment Of Hemorrhoids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva Pharmaceutical Industries Ltd.
- 8.1.1 Teva Pharmaceutical Industries Ltd. Company Information
- 8.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 8.1.3 Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Pharmaceutical Industries Ltd. Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 8.2 Pfizer Inc.
- 8.2.1 Pfizer Inc. Company Information
- 8.2.2 Pfizer Inc. Business Overview
- 8.2.3 Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Inc. Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.2.5 Pfizer Inc. Recent Developments
- 8.3 Olympus Corporation
- 8.3.1 Olympus Corporation Company Information
- 8.3.2 Olympus Corporation Business Overview
- 8.3.3 Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Olympus Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.3.5 Olympus Corporation Recent Developments
- 8.4 Novartis AG
- 8.4.1 Novartis AG Company Information
- 8.4.2 Novartis AG Business Overview
- 8.4.3 Novartis AG Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Novartis AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.4.5 Novartis AG Recent Developments
- 8.5 Johnson & Johnson Services, Inc
- 8.5.1 Johnson & Johnson Services, Inc Company Information
- 8.5.2 Johnson & Johnson Services, Inc Business Overview
- 8.5.3 Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Johnson & Johnson Services, Inc Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.5.5 Johnson & Johnson Services, Inc Recent Developments
- 8.6 GlaxoSmithKline
- 8.6.1 GlaxoSmithKline Company Information
- 8.6.2 GlaxoSmithKline Business Overview
- 8.6.3 GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GlaxoSmithKline Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.6.5 GlaxoSmithKline Recent Developments
- 8.7 F. Hoffmann-La Roche Ltd
- 8.7.1 F. Hoffmann-La Roche Ltd Company Information
- 8.7.2 F. Hoffmann-La Roche Ltd Business Overview
- 8.7.3 F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 F. Hoffmann-La Roche Ltd Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.7.5 F. Hoffmann-La Roche Ltd Recent Developments
- 8.8 Cook Medical
- 8.8.1 Cook Medical Company Information
- 8.8.2 Cook Medical Business Overview
- 8.8.3 Cook Medical Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cook Medical Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.8.5 Cook Medical Recent Developments
- 8.9 CONMED Corporation
- 8.9.1 CONMED Corporation Company Information
- 8.9.2 CONMED Corporation Business Overview
- 8.9.3 CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 CONMED Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.9.5 CONMED Corporation Recent Developments
- 8.10 Boston Scientific Corporation
- 8.10.1 Boston Scientific Corporation Company Information
- 8.10.2 Boston Scientific Corporation Business Overview
- 8.10.3 Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Boston Scientific Corporation Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.10.5 Boston Scientific Corporation Recent Developments
- 8.11 Boehringer Ingelheim GmbH
- 8.11.1 Boehringer Ingelheim GmbH Company Information
- 8.11.2 Boehringer Ingelheim GmbH Business Overview
- 8.11.3 Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Boehringer Ingelheim GmbH Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.11.5 Boehringer Ingelheim GmbH Recent Developments
- 8.12 Bayer AG
- 8.12.1 Bayer AG Company Information
- 8.12.2 Bayer AG Business Overview
- 8.12.3 Bayer AG Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Bayer AG Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.12.5 Bayer AG Recent Developments
- 8.13 AstraZeneca
- 8.13.1 AstraZeneca Company Information
- 8.13.2 AstraZeneca Business Overview
- 8.13.3 AstraZeneca Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 AstraZeneca Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.13.5 AstraZeneca Recent Developments
- 8.14 Abbott Laboratories
- 8.14.1 Abbott Laboratories Company Information
- 8.14.2 Abbott Laboratories Business Overview
- 8.14.3 Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Abbott Laboratories Diagnosis and Treatment Of Hemorrhoids Product Portfolio
- 8.14.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Diagnosis and Treatment Of Hemorrhoids Value Chain Analysis
- 9.1.1 Diagnosis and Treatment Of Hemorrhoids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Diagnosis and Treatment Of Hemorrhoids Production Mode & Process
- 9.2 Diagnosis and Treatment Of Hemorrhoids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Diagnosis and Treatment Of Hemorrhoids Distributors
- 9.2.3 Diagnosis and Treatment Of Hemorrhoids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst